https://www.theguardian.com/business/2025/mar/17/astrazeneca-biotech-cancer-cell-therapy-esobiotec-imfinzi
interesting read.
"
Susan Galbraith, the executive vice-president of oncology research and development at AstraZeneca, said the company had been “looking for things out of the ordinary” and negotiated the deal quickly after seeing EsoBiotec present data from its first patient at JP Morgan’s healthcare conference in San Francisco in mid-January
"
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 5795292 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3258567 | 9 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |